Biotricity

Biotricity Inc. is a publicly traded medical technology company (NASDAQ-listed, 2021) specializing in remote cardiac monitoring and chronic disease management solutions. Founded in 2010 and headquartered in Redwood City, California, the company develops FDA-cleared wearable cardiac monitoring devices and cloud-based platforms for continuous biometric data collection and analysis. Biotricity's product portfolio includes Bioflux® (mobile cardiac telemetry), Biocore (3-channel ECG Holter monitor with 30-day recording), Bioheart (consumer-grade continuous heart rate monitoring), Biokit (multi-vital remote patient monitoring kit), and Biocare (chronic disease management platform). The company operates a dual-revenue model combining recurring Technology-as-a-Service (TaaS) monitoring fees with device hardware sales. Biotricity serves both clinical providers and direct-to-consumer markets, with trusted monitoring for over 100,000+ patients. The platform emphasizes faster diagnosis (3-5 days vs. 2-3 weeks), wireless data transmission via Bluetooth, and physician-reviewed analysis by cardiologists. Biotricity addresses the growing demand for telehealth and proactive cardiac care management, reducing patient risk and improving clinical outcomes.